1. Nogueira RG, Qureshi MM, Abdalkader M, Martins SO, Yamagami H, Qiu Z, et al. Global impact of COVID-19 on stroke care and IV thrombolysis.
Neurology 2021;96:e2824-e2838.
2. Nogueira RG, Abdalkader M, Qureshi MM, Frankel MR, Mansour OY, Yamagami H, et al. Global impact of COVID-19 on stroke care.
Int J Stroke 2021;16:573-584.
3. Nguyen TN, Haussen DC, Qureshi MM, Yamagami H, Fujinaka T, Mansour OY, et al. Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19 pandemic.
Stroke Vasc Neurol 2021;6:542-552.
5. Zhao J, Li H, Kung D, Fisher M, Shen Y, Liu R. Impact of the COVID-19 epidemic on stroke care and potential solutions.
Stroke 2020;51:1996-2001.
6. Kansagra AP, Goyal MS, Hamilton S, Albers GW. Collateral effect of COVID-19 on stroke evaluation in the United States.
N Engl J Med 2020;383:400-401.
7. Ortega-Gutierrez S, Farooqui M, Zha A, Czap A, Sebaugh J, Desai S, et al. Decline in mild stroke presentations and intravenous thrombolysis during the COVID-19 pandemic: the Society of Vascular and Interventional Neurology Multicenter Collaboration.
Clin Neurol Neurosurg 2021;201:106436.
8. Olsen SJ, Azziz-Baumgartner E, Budd AP, Brammer L, Sullivan S, Pineda RF, et al. Decreased influenza activity during the COVID-19 pandemic: United States, Australia, Chile, and South Africa, 2020.
MMWR Morb Mortal Wkly Rep 2020;69:1305-1309.
9. Htun P, Fateh-Moghadam S, Tomandl B, Handschu R, Klinger K, Stellos K, et al. Course of platelet activation and plateletleukocyte interaction in cerebrovascular ischemia.
Stroke 2006;37:2283-2287.
10. Lee KR, Bae JH, Hwang IC, Kim KK, Suh HS, Ko KD. Effect of influenza vaccination on risk of stroke: a systematic review and meta-analysis.
Neuroepidemiology 2017;48:103-110.
11. Lafond KE, Porter RM, Whaley MJ, Suizan Z, Ran Z, Aleem MA, et al. Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: a systematic review and meta-analysis.
PLoS Med 2021;18:e1003550.
12. Research and data to make progress against the world's largest problems. Our World in Data
https://ourworldindata.org. Accessed April 8, 2022.
13. Yavagal DR, Saini V, Inoa V, Gardener HE, Martins SO, Fakey M, et al. International survey of mechanical thrombectomy stroke systems of care during COVID-19 pandemic.
J Stroke Cerebrovasc Dis 2021;30:105806.
14. Srivastava PK, Zhang S, Xian Y, Xu H, Rutan C, Alger HM, et al. Acute ischemic stroke in patients with COVID-19: an analysis from get with the guidelines-stroke.
Stroke 2021;52:1826-1829.
15. Qureshi AI, Baskett WI, Huang W, Shyu D, Myers D, Raju M, et al. Acute ischemic stroke and COVID-19: an analysis of 27676 patients.
Stroke 2021;52:905-912.
16. de Havenon A, Ney JP, Callaghan B, Delic A, Hohmann S, Shippey E, et al. Impact of COVID-19 on outcomes in ischemic stroke patients in the United States.
J Stroke Cerebrovasc Dis 2021;30:105535.
17. Sasanejad P, Afshar Hezarkhani L, Arsang-Jang S, Tsivgoulis G, Ghoreishi A, Kristian B, et al. Safety and outcomes of intravenous thrombolytic therapy in ischemic stroke patients with COVID-19: CASCADE Initiative.
J Stroke Cerebrovasc Dis 2021;30:106121.
18. Leasure AC, Khan YM, Iyer R, Elkind M, Sansing LH, Falcone GJ, et al. Intracerebral hemorrhage in patients with COVID-19: an analysis from the COVID-19 Cardiovascular Disease Registry.
Stroke 2021;52:e321-e323.
19. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features.
Radiology 2020;296:E119-E120.
21. Henry BM, Cheruiyot I, Benoit JL, Lippi G, Prohászka Z, Favaloro EJ, et al. Circulating levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are independent predictors of coronavirus disease 2019 severity: a prospective, observational study.
Semin Thromb Hemost 2021;47:451-455.
24. Strambo D, De Marchis GM, Bonati LH, Arnold M, Carrera E, Galletta S, et al. Ischemic stroke in COVID-19 patients: Mechanisms, treatment, and outcomes in a consecutive Swiss Stroke Registry analysis.
Eur J Neurol 2022;29:732-743.
25. Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome M, et al. Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa.
bioRxiv 2021;Dec. 21. [Preprint].
https://doi.org/10.1101/2021.12.21.21268116.
29. Velavan TP, Meyer CG. Mild versus severe COVID-19: laboratory markers.
Int J Infect Dis 2020;95:304-307.
32. Ma A, Kase CS, Shoamanesh A, Abdalkader M, Pikula A, Sathya A, et al. Stroke and thromboprophylaxis in the era of COVID-19.
J Stroke Cerebrovasc Dis 2021;30:105392.
34. Lallana S, Chen A, Requena M, Rubiera M, Sanchez A, Siegler JE, et al. Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19.
J Clin Neurosci 2021;88:108-112.
36. McAlpine LS, Zubair AS, Maran I, Chojecka P, Lleva P, Jasne AS, et al. Ischemic stroke, inflammation, and endotheliopathy in COVID-19 patients.
Stroke 2021;52:e233-e238.
37. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19.
Lancet 2020;395:1417-1418.
38. Keller E, Brandi G, Winklhofer S, Imbach LL, Kirschenbaum D, Frontzek K, et al. Large and small cerebral vessel involvement in severe COVID-19: detailed clinical workup of a case series.
Stroke 2020;51:3719-3722.
39. Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J, Berger JS. Thrombosis in hospitalized patients with COVID-19 in a New York City health system.
JAMA 2020;324:799-801.
40. Jiménez D, García-Sanchez A, Rali P, Muriel A, Bikdeli B, Ruiz-Artacho P, et al. Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis.
Chest 2021;159:1182-1196.
41. ATTACC Investigators; ACTIV-4a Investigators; REMAP-CAP Investigators, Lawler PR, Goligher EC, Berger JS, et al. Therapeutic anticoagulation with heparin in noncritically ill patients with COVID-19.
N Engl J Med 2021;385:790-802.
42. Lopes RD, de Barros E Silva P, Furtado R, Macedo A, Bronhara B, Damiani LP, et al. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.
Lancet 2021;397:2253-2263.
43. REMAP-CAP Investigators; ACTIV-4a Investigators; ATTACC Investigators, Goligher EC, Bradbury CA, McVerry BJ, et al. Therapeutic anticoagulation with heparin in critically ill patients with COVID-19.
N Engl J Med 2021;385:777-789.
44. INSPIRATION Investigators, Sadeghipour P, Talasaz AH, Rashidi F, Sharif-Kashani B, Beigmohammadi MT, et al. Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: the INSPIRATION randomized clinical trial.
JAMA 2021;325:1620-1630.
45. Chatterjee S, Chakraborty A, Weinberg I, Kadakia M, Wilensky RL, Sardar P, et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis.
JAMA 2014;311:2414-2421.
46. Harris SK, Bone RC, Ruth WE. Gastrointestinal hemorrhage in patients in a respiratory intensive care unit.
Chest 1977;72:301-304.
47. Nguyen TN, Abdalkader M, Jovin TG, Nogueira RG, Jadhav AP, Haussen DC, et al. Mechanical thrombectomy in the era of the COVID-19 pandemic: emergency preparedness for neuroscience teams. A guidance statement from the Society of Vascular and Interventional Neurology.
Stroke 2020;51:1896-1901.
48. Katsanos AH, Palaiodimou L, Zand R, Yaghi S, Kamel H, Navi BB, et al. Changes in stroke hospital care during the COVID-19 pandemic: a systematic review and meta-analysis.
Stroke 2021;52:3651-3660.
49. Siegler JE, Zha AM, Czap AL, Ortega-Gutierrez S, Farooqui M, Liebeskind DS, et al. Influence of the COVID-19 pandemic on treatment times for acute ischemic stroke: the Society of Vascular and Interventional Neurology Multicenter Collaboration.
Stroke 2021;52:40-47.
51. Fuentes B, Alonso de Leciñana M, García-Madrona S, Díaz-Otero F, Aguirre C, Calleja P, et al. Stroke acute management and outcomes during the COVID-19 outbreak: a cohort study from the Madrid Stroke Network.
Stroke 2021;52:552-562.
52. Chen Y, Nguyen TN, Wellington J, Mofatteh M, Yao W, Hu Z, et al. Shortening door-to-needle time by multidisciplinary collaboration and workflow optimization during the COVID-19 pandemic.
J Stroke Cerebrovasc Dis 2022;31:106179.
53. Hall J, Thon JM, Heslin M, Thau L, Yeager T, Siegal T, et al. Tenecteplase improves door-to-needle time in real-world acute stroke treatment.
Stroke Vasc Interv Neurol 2021;1:e000102.
54. Warach SJ, Saver JL. Stroke thrombolysis with tenecteplase to reduce emergency department spread of coronavirus disease 2019 and shortages of alteplase.
JAMA Neurol 2020;77:1203-1204.
55. Meinel TR, Kaesmacher J, Mosimann PJ, Seiffge D, Jung S, Mordasini P, et al. Association of initial imaging modality and futile recanalization after thrombectomy.
Neurology 2020;95:e2331-e2342.
56. Meinel TR, Kaesmacher J, Fischer U. Author response: association of initial imaging modality and futile recanalization after thrombectomy.
Neurology 2021;96:916-917.
57. Siegler JE, Thon JM. Reader response: association of initial imaging modality and futile recanalization after thrombectomy.
Neurology 2021;96:915-916.
58. Kaesmacher J, Chaloulos-Iakovidis P, Panos L, Mordasini P, Michel P, Hajdu SD, et al. Mechanical thrombectomy in ischemic stroke patients with Alberta Stroke Program Early Computed Tomography Score 0-5.
Stroke 2019;50:880-888.
59. Nguyen TN, Abdalkader M, Nagel S, Qureshi MM, Ribo M, Caparros F, et al. Noncontrast computed tomography vs computed tomography perfusion or magnetic resonance imaging selection in late presentation of stroke with largevessel occlusion.
JAMA Neurol 2022;79:22-31.
60. Seker F, Qureshi MM, Möhlenbruch M, Nogueira RG, AbdalKader M, Ribo M, et al. Abstract TMP67: Predictors of unfavourable events despite successful mechanical thrombectomy in the extended window.
Stroke 2022;53(Suppl 1):ATMP67.
61. Nguyen TN, Nogueira RG, Jovin TG. Response by Nguyen et al to letter regarding article, “Mechanical thrombectomy in the era of the COVID-19 pandemic: emergency preparedness for neuroscience teams: a guidance statement from the society of vascular and interventional neurology”.
Stroke 2020;51:e172-e173.
62. Al Kasab S, Almallouhi E, Alawieh A, Levitt MR, Jabbour P, Sweid A, et al. International experience of mechanical thrombectomy during the COVID-19 pandemic: insights from STAR and ENRG.
J Neurointerv Surg 2020;12:1039-1044.
63. Campbell D, Diprose WK, Deng C, Barber PA. General anesthesia versus conscious sedation in endovascular thrombectomy for stroke: a meta-analysis of 4 randomized controlled trials.
J Neurosurg Anesthesiol 2021;33:21-27.
64. AHA/ASA Stroke Council Leadership. Temporary emergency guidance to US stroke centers during the coronavirus disease 2019 (COVID-19) pandemic: on behalf of the American Heart Association/American Stroke Association Stroke Council Leadership.
Stroke 2020;51:1910-1912.
65. Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study.
Lancet Oncol 2020;21:1023-1034.
66. Williams R, Jenkins DA, Ashcroft DM, Brown B, Campbell S, Carr MJ, et al. Diagnosis of physical and mental health conditions in primary care during the COVID-19 pandemic: a retrospective cohort study.
Lancet Public Health 2020;5:e543-e550.
67. Sisó-Almirall A, Kostov B, Sánchez E, Benavent-Àreu J, Paz LG. Impact of the COVID-19 pandemic on primary health care disease incidence rates: 2017 to 2020.
Ann Fam Med 2022;20:63-68.
68. Thau L, Siegal T, Heslin ME, Rana A, Yu S, Kamen S, et al. Decline in rehab transfers among rehab-eligible stroke patients during the COVID-19 pandemic.
J Stroke Cerebrovasc Dis 2021;30:105857.
69. Hatcher-Martin JM, Adams JL, Anderson ER, Bove R, Burrus TM, Chehrenama M, et al. Telemedicine in neurology: Telemedicine Work Group of the American Academy of Neurology update.
Neurology 2020;94:30-38.
70. Nam HS, Park E, Heo JH. Facilitating stroke management using modern information technology.
J Stroke 2013;15:135-143.
71. Wilcock AD, Schwamm LH, Zubizarreta JR, Zachrison KS, Uscher-Pines L, Richard JV, et al. Reperfusion treatment and stroke outcomes in hospitals with telestroke capacity.
JAMA Neurol 2021;78:527-535.
72. Guzik AK, Martin-Schild S, Tadi P, Chapman SN, Al Kasab S, Martini SR, et al. Telestroke across the continuum of care: lessons from the COVID-19 pandemic.
J Stroke Cerebrovasc Dis 2021;30:105802.
74. Yassi N, Hayward KS, Campbell B, Churilov L. Use of the estimand framework to manage the disruptive effects of COVID-19 on stroke clinical trials.
Stroke 2021;52:3739-3747.